Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Generation Bio Co. | 0 | reported | 09 Feb 2026 | tx 13+173,400−17,339 |
| Rubius Therapeutics, Inc. | 0 | reported | 24 Feb 2023 | tx 11+375,000−40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | TENDER | Generation Bio Co. | 1,263 | — | |
| 09 Feb 2026 | TENDER | Generation Bio Co. | 736 | — | |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 6,000 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 3,840 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 3,000 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 2,500 | — | deriv |
| 04 Jun 2025 | GRANT_AWARD | Generation Bio Co. | 30,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Generation Bio Co. | 60,000 | 0.00 USD | deriv |
| 08 Dec 2023 | PURCHASE | Generation Bio Co. | 637 | 1.82 USD | |
| 08 Dec 2023 | PURCHASE | Generation Bio Co. | 7,363 | 1.79 USD | |
| 04 Dec 2023 | PURCHASE | Generation Bio Co. | 12,000 | 1.50 USD | |
| 08 Jun 2023 | GRANT_AWARD | Generation Bio Co. | 25,000 | 0.00 USD | deriv |
| 24 Feb 2023 | SALE | Rubius Therapeutics, Inc. | 10,385 | 0.13 USD | |
| 31 Jan 2023 | EXERCISE | Rubius Therapeutics, Inc. | 7,500 | — | |
| 01 Feb 2023 | SALE | Rubius Therapeutics, Inc. | 3,878 | 0.25 USD | |
| 31 Jan 2023 | EXERCISE | Rubius Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 09 Aug 2022 | EXERCISE | Rubius Therapeutics, Inc. | 12,500 | — | |
| 10 Aug 2022 | SALE | Rubius Therapeutics, Inc. | 5,737 | 0.80 USD | |
| 09 Aug 2022 | EXERCISE | Rubius Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 15 Jul 2022 | GRANT_AWARD | Generation Bio Co. | 38,400 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 125,000 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 31 Aug 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 31 Aug 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |